We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gilead’s antiviral drug remdesivir showed clinical improvement in two-thirds of COVID-19 patients in a study at Los Angeles’ Cedars-Sinai Hospital. Read More
Eli Lilly’s arthritis treatment Olumiant (baricitinib) is being investigated as a potential COVID-19 treatment in one arm of a National Institutes for Allergy and Infectious Diseases adaptive trial. Read More
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) rolled out temporary measures to help speed clinical trials and provide wider access to needed medical devices during the COVID-19 pandemic. Read More
President Trump invoked the Defense Production Act and ordered 3M to prioritize the supply of N95 masks for the U.S. and to stop exporting respirators to Canada and Latin America. Read More
MedTech Europe is calling on the EU and Europe’s national health authorities to increase the availability of reliable IVD tests and to challenge any decision that limits access to personal protective equipment. Read More